Menopause Hormone Therapy: Reduction in Severe Mood Symptoms to 25%

Buzzline

Recent investigations have focused on the impact of menopause hormone therapy on mental health. In a research involving 260 participants, the percentage of individuals experiencing severe mood disturbances decreased from 62.3% to 24.6% after approximately 4.5 months; however, the absence of a distinct control group was noted. Additionally, a smaller study with 20 women indicated a reduction in cognitive fog after a year of using a tailored estriol and progesterone treatment, although the findings were deemed preliminary. An analysis commissioned by the WHO involving over one million women concluded that hormone therapy did not alter the risk of dementia. The FDA has not sanctioned its use for cognitive fog. It is advisable to consult with your healthcare provider regarding the associated risks and advantages. Disclosure: This video contains stock footage and content created or enhanced using AI-assisted tools.  ai-generated

Transcript

00:00Can hormone therapy help the menopause brain?

00:02Three recent studies took a look.

00:04In a study of 260 people, the share with severe mood symptoms fell from 62.3% to 24.6

00:12% after about four and a half months.

00:14But there was no clear control group.

00:16In a small study of 20 women, brain fog improved after 12 months on a customized estrial and progesterone regimen.

00:23And the authors call it preliminary.

00:25And a World Health Organization commissioned analysis of more than one million women found hormone therapy neither raised nor lowered

00:33dementia risk.

00:34The FDA has not approved hormone therapy for brain fog.

00:37If symptoms are affecting your life, talk to your doctor about the risks and benefits.

00:42Disclosure.

00:43This video contains stock footage and content created or enhanced using AI-assisted tools.

Category

Transcript

Recommended